120
Participants
Start Date
July 17, 2012
Primary Completion Date
December 5, 2014
Study Completion Date
December 5, 2014
Maribavir
Tablet for oral administration
Columbia University, New York
Memorial Sloan-Kettering Cancer Center, New York
University of Pittsburg, Pittsburgh
University of Pennsylvania, Philadelphia
Albert Einstein Medical Center, Philadelphia
Johns Hopkins Hospital, Baltimore
Wake Forest Medical Center, Winston-Salem
Medical University of South Carolina, Charleston
Emory University, Atlanta
Duke University Medical Center, Durham
University of Florida, Gainesville
Tampa General Hospital, Tampa
Vanderbilt Medical Center, Nashville
Nationwide Children's Hospital, Columbus
Cleveland Clinic Foundation, Cleveland
University of Michigan, Ann Arbor
Henry Ford Health Care System, Detroit
University of Minnesota Medical Center, Minneapolis
Northwestern University Medical Center, Chicago
University of Chicago, Chicago
University of Nebraska, Omaha
Ochsner Clinic Foundation, New Orleans
Methodist Healthcare System, San Antonio
University of Colorado, Denver
University of Utah, Salt Lake City
UCLA Medical Center, Los Angeles
Stanford University Medical Center, Stanford
University of Washington, Seattle
Fred Hutchinson Cancer Research Center, Seattle
Yale University, New Haven
Brigham and Women's Hospital, Boston
University of Massachusetts, Worcester
Lead Sponsor
Shire
INDUSTRY